The safety and efficacy of ledipasvir/sofosbuvir with or without ribavirin in the treatment of orthotopic liver transplant recipients with recurrent hepatitis C: real-world data-Reference-Cited by-同舟云学术

The safety and efficacy of ledipasvir/sofosbuvir with or without ribavirin in the treatment of orthotopic liver transplant recipients with recurrent hepatitis C: real-world data

Published:2018-07 Issue:7 Volume:30 Page:761-765
ISSN:0954-691X
Container-title:European Journal of Gastroenterology & Hepatology
language:en
Short-container-title:

Author:

Pyrsopoulos Nikolaos,Trilianos Panagiotis,Lingiah Vivek A.,Fung Phoenix,Punnoose Merlin

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference27 articles.

1. The natural history and outcome of liver transplantation in hepatitis C virus-infected recipients;Gane;Liver Transpl,2003

2. Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C;Firpi;Liver Transpl,2002

3. Efficacy and safety of sofosbuvir/ledipasvir for the treatment of patients with hepatitis C virus re-infection after liver transplantation;Ciesek;Transpl Infect Dis,2016

4. Ledipasvir and sofosbuvir in patients with genotype 1 hepatitis C virus infection and compensated cirrhosis: an integrated safety and efficacy analysis;Reddy;Hepatology,2015

5. Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence after liver transplantation – The CO23 ANRS CUPILT study;Coilly;J Hepatol,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevention of Hepatitis C Virus Infection and Liver Cancer;Viruses and Human Cancer;2020-11-18

2. International Liver Transplantation Society Asian Consensus on the Management of Hepatitis C Virus Infection in Resource Limited Setting—From Noncirrhotic to Decompensated Disease and After Liver Transplantation;Transplantation;2019-04

3. Antiviral therapy of hepatitis C with 1 genotype after liver transplantation;Russian Journal of Transplantology and Artificial Organs;2018-09-17